Literature DB >> 11246464

The FMR2 gene, FRAXE and non-specific X-linked mental retardation: clinical and molecular aspects.

J Gecz1.   

Abstract

FRAXE fragile site associated mental retardation remains unique among X-linked mental retardation phenotypes due to its very mild to borderline nature (50< IQ< 85). It is the most prevalent form of non-specific X-linked mental retardation so far delineated, with an estimated incidence of at least 1/50-100,000 males, and with more than 50 families known worldwide. The FRAXE site is within, or immediately adjacent to, the 5' untranslated region of the FMR2 gene. Hyperexpansion of the FRAXE CCG repeat silences transcription of the gene. The structure of FMR2 has been characterized, but its function remains unknown. Gene localizations for numerous (> 75) large families with non-specific X-linked mental retardation (MRX) have been determined so far. Recently the molecular basis for some of them has been unravelled by identification of the responsible genes, which participate in complex common signalling pathways. This review summarises the new data on FRAXE associated mental retardation and the FMR2 gene in the light of the recent discoveries of new genes responsible for other forms of non-specific X-linked mental retardation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11246464     DOI: 10.1017/S0003480000007983

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  12 in total

1.  Highly punctuated patterns of population structure on the X chromosome and implications for African evolutionary history.

Authors:  Charla A Lambert; Caitlin F Connelly; Jennifer Madeoy; Ruolan Qiu; Maynard V Olson; Joshua M Akey
Journal:  Am J Hum Genet       Date:  2010-01       Impact factor: 11.025

Review 2.  The biological effects of simple tandem repeats: lessons from the repeat expansion diseases.

Authors:  Karen Usdin
Journal:  Genome Res       Date:  2008-07       Impact factor: 9.043

Review 3.  Autism spectrum and obsessive-compulsive disorders: OC behaviors, phenotypes and genetics.

Authors:  Suma Jacob; Angeli Landeros-Weisenberger; James F Leckman
Journal:  Autism Res       Date:  2009-12       Impact factor: 5.216

4.  Most Martin-Bell syndrome (FMR1-related disorder) Venezuelan patients did not show CGG expansion but instead display genetic heterogeneity.

Authors:  Yasser Vega; Sergio Arias; Irene Paradisi
Journal:  J Hum Genet       Date:  2016-10-06       Impact factor: 3.172

5.  Cytogenetic analysis of obsessive-compulsive disorder (OCD): identification of a FRAXE fragile site.

Authors:  Qing Wang; Yanghong Gu; James M Ferguson; Qiuyun Chen; Scott Boatwright; James Gardiner; Cheryl Below; Janna Espinosa; David L Nelson; Lisa G Shaffer
Journal:  Am J Med Genet A       Date:  2003-04-01       Impact factor: 2.802

Review 6.  Clinical and neuroimaging review of triplet repeat diseases.

Authors:  Ryo Kurokawa; Mariko Kurokawa; Akihiko Mitsutake; Moto Nakaya; Akira Baba; Yasuhiro Nakata; Toshio Moritani; Osamu Abe
Journal:  Jpn J Radiol       Date:  2022-09-28       Impact factor: 2.701

7.  Autism spectrum disorder: FRAXE mutation, a rare etiology.

Authors:  F Correia; C Café; J Almeida; S Mouga; G Oliveira
Journal:  J Autism Dev Disord       Date:  2015-03

8.  Development and validation in 500 female samples of a TP-PCR assay to identify AFF2 GCC expansions.

Authors:  Cecília Silva; Nuno Maia; Flávia Santos; Bárbara Rodrigues; Isabel Marques; Rosário Santos; Paula Jorge
Journal:  Sci Rep       Date:  2021-07-19       Impact factor: 4.379

9.  Identification of differential splicing genes in gliomas using exon expression profiling.

Authors:  Feng Yu; Wei-Ming Fu
Journal:  Mol Med Rep       Date:  2014-10-27       Impact factor: 2.952

10.  Accumulated common variants in the broader fragile X gene family modulate autistic phenotypes.

Authors:  Beata Stepniak; Anne Kästner; Giulia Poggi; Marina Mitjans; Martin Begemann; Annette Hartmann; Sandra Van der Auwera; Farahnaz Sananbenesi; Dilja Krueger-Burg; Gabriela Matuszko; Cornelia Brosi; Georg Homuth; Henry Völzke; Fritz Benseler; Claudia Bagni; Utz Fischer; Alexander Dityatev; Hans-Jörgen Grabe; Dan Rujescu; Andre Fischer; Hannelore Ehrenreich
Journal:  EMBO Mol Med       Date:  2015-12       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.